1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Multiple Organ Failure in 1 studies
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zacharowski, K | 1 |
| Berkels, R | 1 |
| Olbrich, A | 1 |
| Chatterjee, PK | 1 |
| Cuzzocrea, S | 1 |
| Foster, SJ | 1 |
| Thiemermann, C | 1 |
1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Multiple Organ Failure
| Article | Year |
|---|---|
The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock.
Topics: Animals; Cells, Cultured; Enzyme Inhibitors; Escherichia coli Infections; Guanylate Cyclase; Hemodyn | 2001 |